Endogenous Endothelial Cell Nitric-oxide Synthase Modulates Apoptosis in Cultured Breast Cancer Cells and Is Transcriptionally Regulated by p53*

Nitric oxide can both stimulate and suppress apoptosis. By reverse transcriptase-polymerase chain reaction and sequencing we show that human breast cancer (MCF-7) cells express endothelial cell nitric-oxide synthase (ecNOS), but not other nitric-oxide synthase isoforms. Inhibition of ecNOS activity in MCF-7 cells increased tumor cell apoptosis, and this effect was also seen following treatment with an NO scavenger. In addition, low concentrations of the NO donor sodium nitroprusside inhibited, whereas high concentrations stimulated MCF-7 cell apoptosis. The ecNOS promoter was found to contain a specific binding site for the apoptosis-regulating protein p53. In co-transfection studies wild-type, but not mutant, p53 down-regulated transcription of an ecNOS promoter-luciferase reporter gene construct. In addition, NO donors up-regulated p53 protein levels in MCF-7 cells. These data point to a previously unrecognized p53-dependent regulation of ecNOS expression that may be important both for regulating apoptosis and for avoiding the generation of genotoxic quantities of NO.

[1]  I. Christensen,et al.  Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  Peter A. Jones,et al.  The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53 , 1998, Molecular and Cellular Biology.

[3]  Jun Yokota,et al.  Sp1-Mediated Transcription of the Werner Helicase Gene Is Modulated by Rb and p53 , 1998, Molecular and Cellular Biology.

[4]  J. Pietenpol,et al.  Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. , 1998, Cancer research.

[5]  K. Wu,et al.  Transcriptional Regulation of Endothelial Nitric-oxide Synthase by Lysophosphatidylcholine* , 1998, The Journal of Biological Chemistry.

[6]  G. Ellis,et al.  Nitrite and nitrate analyses: a clinical biochemistry perspective. , 1998, Clinical biochemistry.

[7]  E. Lam,et al.  The p53 Tumor Suppressor Inhibits Transcription of the TATA-less Mouse DP1 Promoter* , 1998, The Journal of Biological Chemistry.

[8]  P. Nicotera,et al.  Nitric oxide: inducer or suppressor of apoptosis? , 1997, Trends in pharmacological sciences.

[9]  Jen-kun Lin,et al.  Suppression of nitric oxide–induced apoptosis by N‐acetyl‐l‐cysteine through modulation of glutathione, bcl‐2, and bax protein levels , 1997, Molecular carcinogenesis.

[10]  G. Kroemer,et al.  Nitric oxide induces apoptosis via triggering mitochondrial permeability transition , 1997, FEBS letters.

[11]  U. Thorgeirsson,et al.  Flavone acetic acid stimulates nitric oxide and peroxynitrite production in subcutaneous mouse tumors. , 1997, Biochemical and biophysical research communications.

[12]  H. Schröder,et al.  Nitric oxide protects endothelial cells from tumor necrosis factor‐α‐mediated cytotoxicity: possible involvement of cyclic GMP , 1997, FEBS letters.

[13]  Y. Kaneda,et al.  In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death. Identification using Sendai virus-coated liposomes. , 1997, Circulation.

[14]  D. S. Lind,et al.  Nitric oxide contributes to adriamycin's antitumor effect. , 1997, The Journal of surgical research.

[15]  C. Harris,et al.  Interactive effects of nitric oxide and the p 53 tumor suppressor gene in carcinogenesis and tumor progression , 2004 .

[16]  V. Schirrmacher,et al.  Activated endothelial cells induce apoptosis in lymphoma cells. , 1997, International journal of oncology.

[17]  Z. Melkova,et al.  Bcl‐2 prevents nitric oxide‐mediated apoptosis and poly(ADP‐ribose) polymerase cleavage , 1997, FEBS letters.

[18]  M. Nehls,et al.  Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.

[19]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[20]  J. Filep,et al.  Nitric oxide co-operates with hydrogen peroxide in inducing DNA fragmentation and cell lysis in murine lymphoma cells. , 1997, The Biochemical journal.

[21]  N. Morgan,et al.  Evidence for the involvement of cGMP and protein kinase G in nitric oxide‐induced apoptosis in the pancreatic B‐cell line, HIT‐T15 , 1997, FEBS letters.

[22]  S. Lipton,et al.  BCL-2 delay apoptosis and PARP cleavage induced by NO donors in GT1-7 cells. , 1996, Neuroreport.

[23]  V. Laudet,et al.  TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53. , 1996, Oncogene.

[24]  A. Harris,et al.  p53 Regulates the Minimal Promoter of the Human Topoisomerase IIα Gene , 1996 .

[25]  M. Horiuchi,et al.  Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. , 1996, Circulation research.

[26]  B. Brüne,et al.  Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. , 1996, The Biochemical journal.

[27]  Jen-kun Lin,et al.  Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells , 1996, Molecular carcinogenesis.

[28]  D. Wink,et al.  Hydroxyurea reacts with heme proteins to generate nitric oxide , 1996, The Lancet.

[29]  C. Harris,et al.  Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Farias-Eisner,et al.  The Chemistry and Tumoricidal Activity of Nitric Oxide/Hydrogen Peroxide and the Implications to Cell Resistance/Susceptibility (*) , 1996, The Journal of Biological Chemistry.

[31]  M. Mandal,et al.  Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  G. Enikolopov,et al.  Nitric oxide, cell multiplication, and cell survival. , 1996, Cold Spring Harbor symposia on quantitative biology.

[33]  K. Son,et al.  In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing. , 1995, Cancer research.

[34]  E. Masini,et al.  Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. , 1995, Cancer research.

[35]  B. Halliwell,et al.  Nitric oxide and oxygen radicals: a question of balance , 1995, FEBS letters.

[36]  Richard Graham Knowles,et al.  Nitric oxide synthase activity in human breast cancer. , 1995, British Journal of Cancer.

[37]  M. Miller,et al.  Nitric oxide induces apoptosis in a human colonic epithelial cell line, T84 , 1995, Mediators of inflammation.

[38]  M. Clarke,et al.  Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. , 1995, Cancer research.

[39]  Thomas T. Y. Wang,et al.  Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. , 1995, Cancer research.

[40]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[41]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[42]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[43]  A. Levine,et al.  Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression , 1995, Molecular and cellular biology.

[44]  J. Stamler,et al.  Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation , 1994, Cell.

[45]  B. Brüne,et al.  p53 expression in nitric oxide‐induced apoptosis , 1994, FEBS letters.

[46]  T. Kawamoto,et al.  Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. , 1994, European journal of biochemistry.

[47]  M. S. Orr,et al.  Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[48]  John Calvin Reed,et al.  Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.

[49]  J. Hickman,et al.  Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. , 1993, The EMBO journal.

[50]  K. Kinzler,et al.  Definition of a consensus binding site for p53 , 1992, Nature Genetics.

[51]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[52]  I. Fidler,et al.  Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. , 1991, Cancer research.

[53]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[54]  T. Edlund,et al.  Sequence-specific interactions of nuclear factors with the insulin gene enhancer , 1986, Cell.